Q3 2026 13F filing
Updated 6 days ago34 disclosed positions worth $2.1B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | O ORUKA THERAPEUTICS INC | $345.5M | 4.15M | 16.79% | — |
| 2 | E ERASCA INC | $294.5M | 20.09M | 14.31% | — |
| 3 | S SPYRE THERAPEUTICS INC | $221.3M | 2.49M | 10.75% | — |
| 4 | K KORSANA BIOSCIENCES INC | $145.6M | 4.55M | 7.07% | — |
| 5 | S SAVARA INC | $101M | 19.57M | 4.91% | — |
| 6 | O OCULAR THERAPEUTIX INC | $79.4M | 10.35M | 3.86% | — |
| 7 | ? N/A DAMORA THERAPEUTICS INC | $76.7M | 3.60M | 3.73% | — |
| 8 | D DIANTHUS THERAPEUTICS INC | $72.4M | 822.0K | 3.52% | — |
| 9 | V VIRIDIAN THERAPEUTICS INC | $67.1M | 3.26M | 3.26% | — |
| 10 | V VOR BIOPHARMA INC | $58M | 3.04M | 2.82% | — |
| 11 | C COGENT BIOSCIENCES INC | $52.6M | 1.64M | 2.55% | — |
| 12 | A ADLAI NORTYE GROUP LTD | $51.4M | 3.21M | 2.50% | — |
| 13 | J JADE BIOSCIENCES INC | $45.2M | 3.22M | 2.20% | — |
| 14 | A ACHIEVE LIFE SCIENCE INC | $44.5M | 5.50M | 2.16% | — |
| 15 | M MAZE THERAPEUTICS INC | $42M | 1.55M | 2.04% | — |
| 16 | O ORIC PHARMACEUTICALS INC | $39.7M | 2.94M | 1.93% | — |
| 17 | D DYNE THERAPEUTICS INC | $35M | 2.17M | 1.70% | — |
| 18 | A ADARX PHARMACEUTICALS INC | $32.4M | 1.63M | 1.58% | — |
| 19 | C CRESCENT BIOPHARMA INC. | $31.1M | 2.13M | 1.51% | — |
| 20 | R RELMADA THERAPEUTICS INC | $28.1M | 7.45M | 1.36% | — |
| 21 | Z ZURA BIO LTD | $26.8M | 6.43M | 1.30% | — |
| 22 | ? N/A X4 PHARMACEUTICALS INC | $22.2M | 7.64M | 1.08% | — |
| 23 | C CULLINAN THERAPEUTICS INC | $21.2M | 1.38M | 1.03% | — |
| 24 | ? N/A SURROZEN INC | $20.4M | 632.9K | 0.99% | — |
| 25 | P PARABILIS MEDICINES INC | $20.2M | 625.0K | 0.98% | — |
| 26 | A ARVINAS INC | $15.1M | 1.95M | 0.73% | — |
| 27 | C CENTURY THERAPEUTICS INC | $14.9M | 8.70M | 0.72% | — |
| 28 | E ENTERA BIO LTD | $14.9M | 5.11M | 0.72% | — |
| 29 | A ARTIVA BIOTHERAPEUTICS INC | $14.6M | 2.04M | 0.71% | — |
| 30 | A ALTO NEUROSCIENCE INC | $12.8M | 500.0K | 0.62% | — |
| 31 | K KORRO BIO INC | $4.4M | 443.4K | 0.21% | — |
| 32 | ? N/A TCGX ACQUISITION CORP | $3.8M | 300.0K | 0.18% | — |
| 33 | R RESEARCH ALLIANCE CORP IV | $3.6M | 300.0K | 0.17% | — |
| 34 | I INMED PHARMACEUTICALS INC | $181K | 133.4K | 0.01% | — |